People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Valtech Cardio: The Israeli start-up named former Boston Scientific executive Bruce H. KenKnight its new president and CEO Feb. 9. KenKnight most recently served as VP-Research and Business Development for Boston Sci's Cardiac Rhythm Management division. Earlier this month, Valtech raised $17.8 million in a Series B financing to aid its development of minimally invasive surgical and transcatheter mitral valve repair and replacement devices